Barclays’s Mustang Bio MBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-83
| Closed | -$9K | – | 4289 |
|
|
2023
Q3 | $9K | Hold |
83
| – | – | ﹤0.01% | 4041 |
|
|
2023
Q2 | $26K | Buy |
+83
| New | +$26K | ﹤0.01% | 3918 |
|
|
2022
Q4 | – | Sell |
-86
| Closed | -$30K | – | 4463 |
|
|
2022
Q3 | $30K | Sell |
86
-7
| -8% | -$2.44K | ﹤0.01% | 3817 |
|
|
2022
Q2 | $41K | Sell |
93
-16
| -15% | -$7.05K | ﹤0.01% | 3804 |
|
|
2022
Q1 | $83K | Sell |
109
-102
| -48% | -$77.7K | ﹤0.01% | 3754 |
|
|
2021
Q4 | $263K | Buy |
211
+91
| +76% | +$113K | ﹤0.01% | 2748 |
|
|
2021
Q3 | $242K | Buy |
120
+53
| +79% | +$107K | ﹤0.01% | 2897 |
|
|
2021
Q2 | $166K | Sell |
67
-44
| -40% | -$109K | ﹤0.01% | 2960 |
|
|
2021
Q1 | $277K | Buy |
111
+89
| +405% | +$222K | ﹤0.01% | 2985 |
|
|
2020
Q4 | $61K | Buy |
22
+5
| +29% | +$13.9K | ﹤0.01% | 3115 |
|
|
2020
Q3 | $41K | Sell |
17
-4
| -19% | -$9.65K | ﹤0.01% | 3352 |
|
|
2020
Q2 | $50K | Buy |
21
+9
| +75% | +$21.4K | ﹤0.01% | 3401 |
|
|
2020
Q1 | $25K | Sell |
12
-25
| -68% | -$52.1K | ﹤0.01% | 3330 |
|
|
2019
Q4 | $114K | Buy |
37
+19
| +106% | +$58.5K | ﹤0.01% | 3411 |
|
|
2019
Q3 | $45K | Sell |
18
-6
| -25% | -$15K | ﹤0.01% | 3711 |
|
|
2019
Q2 | $66K | Buy |
24
+18
| +300% | +$49.5K | ﹤0.01% | 3753 |
|
|
2019
Q1 | $16K | Buy |
+6
| New | +$16K | ﹤0.01% | 3950 |
|
|
2018
Q4 | – | Sell |
-8
| Closed | -$36K | – | 4249 |
|
|
2018
Q3 | $36K | Buy |
8
+6
| +300% | +$27K | ﹤0.01% | 3829 |
|
|
2018
Q2 | $8K | Sell |
2
-8
| -80% | -$32K | ﹤0.01% | 3946 |
|
|
2018
Q1 | $81K | Buy |
+10
| New | +$81K | ﹤0.01% | 3267 |
|